Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
69
PSO Quote, Financials, Valuation and Earnings
Last price:
$15.92
Seasonality move
:
3.61%
Day range:
$15.76 - $15.98
52-week range:
$11.69 - $16.30
Dividend yield:
1.84%
P/E ratio:
25.67x
P/S ratio:
2.52x
P/B ratio:
2.20x
Volume:
773.5K
Avg. volume:
383.4K
1-year change:
32.42%
Market cap:
$10.6B
Revenue:
$4.6B
EPS (TTM):
$0.62
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.4B | $4.7B | $4.8B | $4.6B | |
| Revenue Growth (YoY) | -10.33% | -11.75% | 8.17% | 0.86% | -3.89% | |
| Cost of Revenues | $2.4B | $2.3B | $2.4B | $2.5B | $2.3B | |
| Gross Profit | $2.6B | $2.1B | $2.3B | $2.2B | $2.3B | |
| Gross Profit Margin | 51.98% | 47.98% | 49.04% | 46.73% | 49.95% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.2B | $1.9B | $1.9B | $1.8B | $1.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.1B | $1.8B | $1.9B | $1.7B | $1.6B | |
| Operating Income | $462.2M | $292.6M | $458.1M | $490.4M | $638.3M | |
| Net Interest Expenses | $35.8M | $70.6M | $72.9M | $2.5M | $13.7M | |
| EBT. Incl. Unusual Items | $296.2M | $487.7M | $243.5M | $400M | $613.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$43.4M | $64.2M | -$1.4M | $97.8M | $140.6M | |
| Net Income to Company | $339.6M | $487.7M | $243.5M | $400M | $613.5M | |
| Minority Interest in Earnings | -$2.6M | -- | -$1.4M | -$2.5M | -$2.5M | |
| Net Income to Common Excl Extra Items | $337.1M | $423.5M | $243.5M | $299.7M | $470.4M | |
| Basic EPS (Cont. Ops) | $0.43 | $0.56 | $0.32 | $0.41 | $0.66 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.56 | $0.32 | $0.40 | $0.66 | |
| Weighted Average Basic Share | $777M | $755.4M | $754.1M | $738.1M | $711.5M | |
| Weighted Average Diluted Share | $777.5M | $755.4M | $759.1M | $742M | $717.3M | |
| EBITDA | $878.5M | $1.4B | $1.3B | $1.3B | $1.4B | |
| EBIT | $381.8M | $589.1M | $337.1M | $485.4M | $689.4M | |
| Revenue (Reported) | $4.9B | $4.4B | $4.7B | $4.8B | $4.6B | |
| Operating Income (Reported) | $462.2M | $292.6M | $458.1M | $490.4M | $638.3M | |
| Operating Income (Adjusted) | $381.8M | $589.1M | $337.1M | $485.4M | $689.4M | |
| Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2012-12-31 | 2013-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | 131.43% | -26.88% | 5.28% | 22.66% | 2.6% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.7B | $4.7B | $4.8B | $4.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.3B | $2.4B | $2.4B | $2.5B | $2.2B | |
| Gross Profit | $2.2B | $2.4B | $2.3B | $2.3B | $2.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.8B | $1.9B | $1.7B | $1.7B | $1.6B | |
| Operating Income | $355.4M | $422.1M | $598.4M | $587.3M | $635.2M | |
| Net Interest Expenses | $51.7M | $75.8M | $17.6M | $22.4M | $26.3M | |
| EBT. Incl. Unusual Items | $325.5M | $460.8M | $465.8M | $457.7M | $586.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$14.8M | $63.6M | $79.1M | $96.6M | $147.6M | |
| Net Income to Company | $340.4M | $443.6M | $465.8M | $457.7M | $586.7M | |
| Minority Interest in Earnings | -$1.3M | -$1.4M | -- | -$3.6M | -$2.5M | |
| Net Income to Common Excl Extra Items | $339.1M | $395.8M | $386.7M | $357.5M | $436.5M | |
| Basic EPS (Cont. Ops) | $0.44 | $0.53 | $0.51 | $0.50 | $0.63 | |
| Diluted EPS (Cont. Ops) | $0.44 | $0.52 | $0.51 | $0.49 | $0.62 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $924.3M | $1.6B | $1.3B | $1.3B | $1.4B | |
| EBIT | $422.1M | $567.1M | $528.6M | $549.3M | $672.8M | |
| Revenue (Reported) | $4.5B | $4.7B | $4.7B | $4.8B | $4.4B | |
| Operating Income (Reported) | $355.4M | $422.1M | $598.4M | $587.3M | $635.2M | |
| Operating Income (Adjusted) | $422.1M | $567.1M | $528.6M | $549.3M | $672.8M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $573M | $1.5B | $1.3B | $675.3M | $397.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.2B | $1.1B | $1.2B | $997.2M | $884.1M | |
| Inventory | $221.6M | $175.8M | $132.3M | $127.1M | $115.9M | |
| Prepaid Expenses | $186.2M | $260.3M | $269.9M | $243.3M | $298.1M | |
| Other Current Assets | $1.1B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Total Current Assets | $4.2B | $4.6B | $4.3B | $3.4B | $3.1B | |
| Property Plant And Equipment | $810.3M | $701.9M | $494M | $302.6M | $276.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.8B | $2.9B | $2.9B | $3B | $3.1B | |
| Other Intangibles | $997.8M | $883.1M | $842.2M | $843.5M | $837M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $10B | $10.2B | $9.9B | $8.9B | $8.6B | |
| Accounts Payable | $469.4M | $463.4M | $473.7M | $421.1M | $403.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $116.7M | $99.5M | $91.8M | $85.9M | $81.5M | |
| Other Current Liabilities | $365.8M | $293M | $112M | $64.1M | $39.5M | |
| Total Current Liabilities | $2B | $2.2B | $2.1B | $1.8B | $1.8B | |
| Long-Term Debt | $1.1B | $1.1B | $917.8M | $738.2M | $778.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.4B | $4.5B | $4.1B | $3.5B | $3.5B | |
| Common Stock | $255.7M | $256.2M | $255.1M | $216.6M | $221.7M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $5.7B | $5.6B | $5.8B | $5.3B | $5.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $13.1M | $12.3M | $13.5M | $15.7M | $17.8M | |
| Total Equity | $5.7B | $5.6B | $5.8B | $5.3B | $5.1B | |
| Total Liabilities and Equity | $10B | $10.2B | $9.9B | $8.9B | $8.6B | |
| Cash and Short Terms | $573M | $1.5B | $1.3B | $675.3M | $397.5M | |
| Total Debt | $1.1B | $1.3B | $1B | $756.4M | $782.2M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $845.6M | $896.8M | $475.5M | $447.8M | $419.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.3B | $1.6B | $1.4B | $1.3B | $1.4B | |
| Inventory | $214.2M | $174.4M | $124.9M | $138.7M | $112.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.2B | $1.1B | $1.2B | $1.2B | |
| Total Current Assets | $3.5B | $4.1B | $3.4B | $3.2B | $3.2B | |
| Property Plant And Equipment | $784.1M | $627M | $354.2M | $285.1M | $261.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.8B | $2.9B | $3B | $3.1B | $3.1B | |
| Other Intangibles | $929.3M | $848.4M | $902.4M | $864M | $776.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $9.3B | $9.6B | $9.1B | $8.7B | $8.5B | |
| Accounts Payable | $265.9M | $1.5B | $1.5B | $1.3B | $1.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $96.9M | $88.5M | $87M | $79.7M | |
| Other Current Liabilities | $249.9M | -- | -- | -- | -- | |
| Total Current Liabilities | $1.8B | $1.9B | $1.8B | $1.5B | $1.8B | |
| Long-Term Debt | -- | $938.4M | $720.5M | $1B | $1.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.1B | $4B | $3.6B | $3.4B | $3.7B | |
| Common Stock | $231.4M | $261.6M | $224.4M | $225.8M | $211.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $12.3M | $13.8M | $13.3M | $16.4M | $19M | |
| Total Equity | $5.2B | $5.6B | $5.4B | $5.3B | $4.8B | |
| Total Liabilities and Equity | $9.3B | $9.6B | $9.1B | $8.7B | $8.5B | |
| Cash and Short Terms | $845.6M | $896.8M | $475.5M | $447.8M | $419.9M | |
| Total Debt | $2.3B | $1.1B | $813.8M | $1B | $1.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $339.6M | $487.7M | $243.5M | $400M | $613.5M | |
| Depreciation & Amoritzation | $496.7M | $766.2M | $945.1M | $765.3M | $675.7M | |
| Stock-Based Compensation | $31.9M | $37.2M | $38.5M | $43.3M | $49.8M | |
| Change in Accounts Receivable | $75.3M | -$1.3M | -$97.7M | $40.9M | -$29.9M | |
| Change in Inventories | -$25.5M | $44.9M | $30.3M | -$42.1M | $11.2M | |
| Cash From Operations | $471.2M | $499.3M | $448.5M | $447M | $653.3M | |
| Capital Expenditures | $246.4M | $172M | $242.1M | $182M | $156.8M | |
| Cash Acquisitions | -$237.5M | $802.2M | $24.8M | $123.8M | -$266.3M | |
| Cash From Investing | -$415M | $758.5M | -$110.1M | $16.1M | -$374.5M | |
| Dividends Paid (Ex Special Dividend) | -$187.7M | -$187.4M | -$205M | -$193.2M | -$191.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $293.7M | $444.1M | -- | -- | $354.6M | |
| Long-Term Debt Repaid | -$61.3M | -$295.2M | -$229.7M | -$211.8M | -$354.6M | |
| Repurchase of Common Stock | -$66.4M | -$233.6M | -$22M | -$483M | -$275M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$130.2M | -$383.8M | -$569.6M | -$995.6M | -$559.9M | |
| Beginning Cash (CF) | $670.4M | $557M | $1.5B | $1.2B | $675.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$74.1M | $874M | -$231.1M | -$532.5M | -$281.2M | |
| Ending Cash (CF) | $554.2M | $1.4B | $1.3B | $672.4M | $384.5M | |
| Levered Free Cash Flow | $224.7M | $327.3M | $206.4M | $265M | $496.5M | |
| Period Ending | 2004-06-30 | 2005-06-30 | 2006-06-30 | 2007-06-30 | 2008-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.3M | $641.2M | $36.6M | -- | -$96.6M | |
| Depreciation & Amoritzation | -- | $220.7M | -- | -- | $163.7M | |
| Stock-Based Compensation | -- | -- | -- | -- | $31.5M | |
| Change in Accounts Receivable | -- | -$57M | -- | -- | -$96.6M | |
| Change in Inventories | -- | -$129.5M | -- | -- | -$207M | |
| Cash From Operations | $16.3M | -$259M | -$429.6M | -- | -$467.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$36.1M | $721M | -$495.9M | -- | -$493M | |
| Cash From Investing | -$70.5M | $491M | -$519.6M | -- | -$554.1M | |
| Dividends Paid (Ex Special Dividend) | -$215M | -$232.1M | -$248.4M | -- | -$351M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $847.3M | -- | -- | -- | $1.3B | |
| Long-Term Debt Repaid | -$77.7M | -- | -- | -- | -$199.2M | |
| Repurchase of Common Stock | -$3.6M | -$20.7M | -$49.5M | -- | -$39.4M | |
| Other Financing Activities | $213.2M | $1M | -$20.8M | -- | $39.4M | |
| Cash From Financing | $758.8M | $107.7M | $556.3M | -- | $761.1M | |
| Beginning Cash (CF) | -- | $1B | $1.5B | -- | $970.1M | |
| Foreign Exchange Rate Adjustment | -- | $42.5M | -$38.6M | -- | $29.6M | |
| Additions / Reductions | $41.6M | $339.8M | -$392.9M | -- | -$260.3M | |
| Ending Cash (CF) | $41.6M | $1.4B | $1.1B | -- | $739.4M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $340.4M | $443.6M | $465.8M | $457.7M | $586.7M | |
| Depreciation & Amoritzation | $502.2M | $1B | $813.1M | $745.5M | $682.1M | |
| Stock-Based Compensation | $29.1M | $44.8M | $38.8M | $43.8M | $55.1M | |
| Change in Accounts Receivable | $198.7M | -$108.1M | -$102.4M | -$2.7M | -$47.9M | |
| Change in Inventories | $47.7M | $41.9M | -$7.7M | -$11.3M | $23.6M | |
| Cash From Operations | $513.2M | $597.1M | $499.1M | $479.6M | $730.5M | |
| Capital Expenditures | $223M | $171.7M | $227.1M | $172.9M | $151.4M | |
| Cash Acquisitions | $670.2M | $30.3M | -$98.6M | $8.6M | -$76.6M | |
| Cash From Investing | $580.2M | -$96M | -$191.1M | -$111.4M | -$173M | |
| Dividends Paid (Ex Special Dividend) | -$184.5M | -$201.9M | -$197.9M | -$190.3M | -$194.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $73.3M | -- | -- | $275.4M | $705.3M | |
| Long-Term Debt Repaid | -$272.3M | -$233.4M | -$119.4M | -$89.4M | -$354M | |
| Repurchase of Common Stock | -$233.7M | -$16.3M | -$220.9M | -$295.9M | -$640.9M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$718.3M | -$565.2M | -$660.7M | -$398.4M | -$574.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $335.1M | -$82.5M | -$362.2M | -$50.2M | -$10.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $290.2M | $425.4M | $272M | $306.6M | $579.1M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get PSO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PSO
Sector
P/E ratio
25.67x
16.83x
PEG ratio
1.21x
0.22x
P/B ratio
2.20x
1.45x
Price / LTM sales
2.52x
0.71x
Growth Metrics
PSO
Sector
Revenue growth
--
0.14%
Earnings growth
--
--
Revenue (5-year growth)
-3.66%
3.45%
Earnings forecast
--
$0.30
Profitability
PSO
Sector
Profitability FY 2023
$2.3B
$503.7M
Return on invested capital
7.12%
5.17%
Return on assets
5.09%
3.13%
Return on equity
8.63%
7.63%
Earnings Date
Last Earnings Date
Jul
29
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Oct
28
Balance Sheet
PSO
Sector
Total cash
$419.9M
$157.7M
Short term investments
--
$60.7M
Total assets
$8.6B
$1.7B
Long term debt
$1.4B
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
